0

Liver Disease Collection
 1-14 of 14 Articles
ACP Journal Club |  15 October 2013
Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy
Kris V. Kowdley, MD, FACP; Blaire E. Burman, MD
Ann Intern Med. 2013;159(8):JC8. doi:10.7326/0003-4819-159-8-201310150-02008
ACP Journal Club |  16 November 2010
Early use of TIPS in patients with cirrhosis and variceal bleeding
Jacob Korula, MD; Juan Carlos Garcia-Pagán, MD; Jaime Bosch, MD
Ann Intern Med. 2010;153(10):JC5-13. doi:10.7326/0003-4819-153-10-201011160-02013
ACP Journal Club |  19 October 2010
Early use of transjugular intrahepatic portosystemic shunts improved outcomes in patients with cirrhosis and variceal bleeding
Jacob Korula, MD
Ann Intern Med. 2010;153(8):JC4-6. doi:10.7326/0003-4819-153-8-201010190-02006
ACP Journal Club |  21 September 2010
Vitamin E, but not pioglitazone, improved nonalcoholic steatohepatitis in nondiabetic patients
Sandeep Mukherjee, MD
Ann Intern Med. 2010;153(6):JC3-12. doi:10.7326/0003-4819-153-6-201009210-02012
ACP Journal Club |  17 August 2010
Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis
Brian T. Story, MD; Kris V. Kowdley, MD, FACP
Ann Intern Med. 2010;153(4):JC2-8. doi:10.7326/0003-4819-153-4-201008170-02008
ACP Journal Club |  17 August 2010
Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infection
Juerg Reichen, MD
Ann Intern Med. 2010;153(4):JC2-7. doi:10.7326/0003-4819-153-4-201008170-02007
ACP Journal Club |  21 July 2009
Immediate listing for liver transplantation did not differ from usual care for overall survival in stage B alcoholic cirrhosis
Jacob Korula, MD
Ann Intern Med. 2009;151(2):JC1-14. doi:10.7326/0003-4819-151-2-200907210-02014
ACP Journal Club |  16 June 2009
Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin
Matthew Rondina, MD
Ann Intern Med. 2009;150(12):JC6-9. doi:10.7326/0003-4819-150-12-200906160-02009
ACP Journal Club |  19 May 2009
Review: Evidence is insufficient to evaluate effectiveness of antiviral therapies for chronic hepatitis B
J. Reichen, MD
Ann Intern Med. 2009;150(10):JC5-6. doi:10.7326/0003-4819-150-10-200905190-02006
ACP Journal Club |  21 April 2009
Review: Interferon and nucleoside/tide analogues reduce risk for hepatocellular cancer in patients with chronic hepatitis B
Averell H. Sherker, MD, FRCP(C)
Ann Intern Med. 2009;150(8):JC4-11. doi:10.7326/0003-4819-150-8-200904210-02011
ACP Journal Club |  18 November 2008
Review: Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy
Joe Alcorn, MD
Ann Intern Med. 2008;149(10):JC5-11. doi:10.7326/0003-4819-149-10-200811180-02011
ACP Journal Club |  18 November 2008
Review: Endoscopic plus drug therapy prevents rebleeding more than either one alone in cirrhosis with bleeding esophageal varices
Jacob Korula, MD
Ann Intern Med. 2008;149(10):JC5-10. doi:10.7326/0003-4819-149-10-200811180-02010
ACP Journal Club |  19 August 2008
Review: Limited evidence suggests that statins are safe in patients with liver disease
Eric R. Bates, MD
Ann Intern Med. 2008;149(4):JC2-12. doi:10.7326/0003-4819-149-4-200808190-02012
ACP Journal Club |  20 May 2008
Review: Primary prophylaxis with banding ligation or β-blockers does not differ for mortality in esophageal varices
Jacob Korula, MD, FRCPC, FACP
Ann Intern Med. 2008;148(10):JC3-10. doi:10.7326/0003-4819-148-10-200805200-02010
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)